Thursday, 05. August 2010 |
Cystic fibrosis: Does hypertonic saline improve nutritional status?
Results were presented at this year’s European Cystic Fibrosis Conference from a study in which BMI had significantly increased for 14 cystic fibrosis patients after inhaling hypertonic saline for at least 18 months.
[more]
Monday, 19. July 2010 |
PARI SINUS and dornase alfa: an efficient tandem team in treating chronic rhinosinusitis
Chronic rhinosinusitis is a complex condition that is quite common and considerably compromises the quality of life in cystic fibrosis patients. In a study conducted with the mucolytic drug dornase alfa via PARI SINUS, cystic...
[more]
Monday, 21. June 2010 |
PARI LC SPRINT: nebuliser of choice for clinical trials with inhaled antibiotic
The main advantage of inhaled antibiotic therapy is that the drug directly reaches the site of action and reduces adverse events for the entire organism. Recent results from ongoing clinical trials with ciprofloxacin – an...
[more]